RPE65 and Leber congenital amaurosis: In our series, a total of six (four RP and two LCA) nonrelated probands were found to harbor biallelic changes in RPE65. In our study, a total of 12 individuals (including probands and affected relatives in familial cases) can be considered as candidates to receive RPE65 therapy for their disease.